4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-021728
EVP, R&D & Chief Scientific Of sold 18,327 shares at an average $39.79 ($729,265)
From the SEC's structured data for this filing
Trades in this filing
Haqq Christopher · EVP, R&D & Chief Scientific Of
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-26 | Sale : show line 1 in the form | −17,227 | $39.76 | $684,946 | 334,005 | D |
| 2018-03-26 | Sale : show line 2 in the form | −1,100 | $40.29 | $44,319 | 332,905 | D |
| Open-market sales · 18,327 sh · avg $39.79 · $729,265 | ||||||
Loading xslF345X03/doc4.xml…